[Empirical utilization of antibiotic combinations (ticarcillin-tobramycin, cephalothin-tobramycin and ticarcillin-cephalothin). A preliminary study].
D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria; D001424:Bacterial Infections / Q000188:drug therapy*; D002264:Carboxylic Acids / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007668:Kidney / Q000187:drug effects; D010406:Penicillins / Q000627:therapeutic use*; D013223:Statistics as Topic; D013876:Thiophenes / Q000627:therapeutic use*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D010406:Penicillins; D013876:Thiophenes; D002512:Cephalothin
Utilisation empirique de combinaisons d'antibiotiques (ticarcilline-tobramycine, céfalotin-tobramycine et ticarcilline-céfalotine). Etude préliminaire